See also this year's filing and all EDGAR filings for this company.
PDF Report 0001346302_2020_XERIS_PHARMACEUTICALS_INC.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001346302')"} |
Graph
Absolute values for 0001346302, XERIS PHARMACEUTICALS INC
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 87,483,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 7,853,000 |
3 | remainder_Assets | 13,651,000 |
4 | LiabilitiesCurrent | 27,338,000 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 67,213,000 |
7 | CostOfGoodsAndServicesSold | 1,603,000 |
8 | SellingGeneralAndAdministrativeExpense | 63,061,000 |
9 | ResearchAndDevelopmentExpense | 60,438,000 |
10 | remainder_Expenses | -458,000 |
11 | remainder_Revenues | 1,627,000 |
12 | remainder_NetIncome | -2,563,000 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 108,987,000 |
1 | Liabilities | 94,551,000 |
2 | Expenses | 124,644,000 |
3 | Revenues | 1,627,000 |
4 | StockholdersEquity | 14,436,000 |
5 | NetIncome | -125,580,000 |
6 | ComprehensiveNetIncome | -125,580,000 |
7 | BaseVar | 166,186,000 |
8 | EconomicCapitalRatio | -0.990 |